Bradley Foster & Sargent Inc. CT Raises Holdings in Novanta Inc. $NOVT

Bradley Foster & Sargent Inc. CT boosted its position in Novanta Inc. (NASDAQ:NOVT) by 24.1% during the first quarter, Holdings Channel.com reports. The fund owned 128,861 shares of the technology company’s stock after purchasing an additional 25,056 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in Novanta were worth $15,220,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in NOVT. Caxton Associates LLP purchased a new stake in Novanta during the first quarter valued at about $1,362,000. Gibbs Wealth Management raised its holdings in shares of Novanta by 156.5% in the 1st quarter. Gibbs Wealth Management now owns 12,806 shares of the technology company’s stock worth $1,513,000 after purchasing an additional 7,814 shares during the period. Sei Investments Co. raised its holdings in shares of Novanta by 47.6% in the 1st quarter. Sei Investments Co. now owns 484,316 shares of the technology company’s stock worth $57,203,000 after purchasing an additional 156,263 shares during the period. Group One Trading LLC purchased a new position in shares of Novanta in the 1st quarter worth about $177,000. Finally, State of Wyoming acquired a new position in shares of Novanta in the 1st quarter valued at about $333,000. Institutional investors and hedge funds own 98.35% of the company’s stock.

Analyst Ratings Changes

NOVT has been the subject of a number of research reports. Wall Street Zen upgraded Novanta from a “hold” rating to a “buy” rating in a report on Saturday, June 27th. Weiss Ratings restated a “hold (c-)” rating on shares of Novanta in a report on Wednesday, July 15th. Finally, Robert W. Baird set a $180.00 price target on shares of Novanta in a research report on Tuesday, June 9th. One investment analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, Novanta presently has a consensus rating of “Hold” and an average target price of $180.00.

Insider Activity

In other news, CEO Matthijs Glastra sold 6,500 shares of the stock in a transaction dated Thursday, July 2nd. The stock was sold at an average price of $161.13, for a total value of $1,047,345.00. Following the completion of the sale, the chief executive officer owned 29,761 shares in the company, valued at approximately $4,795,389.93. This trade represents a 17.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.20% of the company’s stock.

Novanta Stock Down 1.2%

Shares of Novanta stock opened at $141.54 on Friday. Novanta Inc. has a twelve month low of $98.27 and a twelve month high of $171.85. The stock has a market cap of $5.34 billion, a price-to-earnings ratio of 102.57 and a beta of 1.67. The company has a current ratio of 3.56, a quick ratio of 2.69 and a debt-to-equity ratio of 0.15. The company has a fifty day moving average price of $155.63 and a 200 day moving average price of $140.10.

Novanta (NASDAQ:NOVT) last released its quarterly earnings data on Monday, May 11th. The technology company reported $0.81 EPS for the quarter, beating the consensus estimate of $0.78 by $0.03. The company had revenue of $257.71 million for the quarter, compared to analyst estimates of $253.40 million. Novanta had a return on equity of 12.06% and a net margin of 5.35%.The firm’s revenue was up 10.4% compared to the same quarter last year. During the same period last year, the company posted $0.74 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. Equities research analysts forecast that Novanta Inc. will post 3.59 earnings per share for the current fiscal year.

Novanta Company Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.